Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Clinician-administered Vaginal Live Biotherapeutic Product
Sponsor: Caroline Mitchell
Summary
This is an open-label, single-arm, Phase Ib trial assessing the consistency of response and colonization kinetics of a vaginally inserted live biotherapeutic intervention with optimized adherence.
Official title: Open-label, Single-arm Study to Assess the Colonization Kinetics of Clinician- Administered Vaginal Live Biotherapeutic Product Containing Multiple Strains of Lactobacillus Crispatus.
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
71
Start Date
2026-02-10
Completion Date
2026-05-30
Last Updated
2026-01-20
Healthy Volunteers
No
Conditions
Interventions
LC106
This is a 6-strain L. crispatus vaginal live biotherapeutic tablet
Locations (2)
Massachusetts General Hospital
Boston, Massachusetts, United States
CAPRISA
Vulindlela, South Africa